4.7 Article

The epidemiology of ocular and nasal allergy in the United States, 1988-1994

期刊

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
卷 126, 期 4, 页码 778-U150

出版社

MOSBY-ELSEVIER
DOI: 10.1016/j.jaci.2010.06.050

关键词

Ocular allergy; epidemiology; nasal allergy symptoms; seasonal allergic conjunctivitis; perennial allergic conjunctivitis; vernal keratoconjunctivitis; atopic keratoconjunctivitis; giant papillary conjunctivitis

资金

  1. EPA STAR [R834547]
  2. EPA [150294, R834547] Funding Source: Federal RePORTER

向作者/读者索取更多资源

Background: Allergies give rise to the fifth-leading group of chronic diseases. However, the specific prevalence of ocular allergy is poorly described. Objective: We sought to provide a more accurate representation of the epidemiology of ocular allergy in the United States. Methods: The National Health And Nutrition Examination Survey III performed in the United States from 1988-1994 was the source for the data collected. Items from the questionnaire regarding ocular and nasal allergy symptoms in relation to skin prick testing were stratified by age, race, region, and sex. Results: The sample size is 20,010: 1,285 (6.4%) reported ocular symptoms, 3,294 (16.5%) reported nasal symptoms, 5,944 (29.7%) reported both ocular and nasal symptoms, and 9.487 (47.4%) were asymptomatic. Forty percent of the population reported at least 1 occurrence of ocular symptoms in the past 12 months. Those 50 years and older have a higher frequency of isolated ocular symptoms (P < .001). There is an increase in the frequency of symptoms in those younger than 50 years in the populations of subjects with ocular and nasal symptoms combined and isolated nasal symptoms (P < .001). Ocular symptoms are more frequent than nasal symptoms in relation to animals (P < .001), household dust (P < .001), and pollen (P < .001). Conclusion: This analysis provides the first representation of the epidemiology of ocular allergy in the United States. Up to 40% of the population, the highest reported to date, have experienced ocular symptoms at least once in their lifetime, with a peak of symptoms in the months of June and July. (J Allergy Clin Immunol 2010;126:778-83.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据